Generate Biomedicines, Inc. ($GENB)
Filing Information
| Accession Number | 0001193125-26-085898 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
572,101
Total Value
$32,000.00
P&L
+21729.2% (+$6,953,353.21)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & CFO | Common Stock | โ | Mar 2, 2026 | Purchase | 500 | $16.00 | $8,000.00 | 500 | Indirect | By daughter | View Details | |
President & CFO | Common Stock | โ | Mar 2, 2026 | Purchase | 500 | $16.00 | $8,000.00 | 500 | Indirect | By daughter | View Details | |
President & CFO | Common Stock | โ | Mar 2, 2026 | Purchase | 1,000 | $16.00 | $16,000.00 | 1,000 | Indirect | By son | View Details | |
President & CFO | Stock Option (Right to Buy) | Derivative | Feb 26, 2026 | Grant/Award | 295,608 | $0.00 | $0.00 | 295,608 | Direct | โ | View Details | |
President & CFO | Stock Option (Right to Buy) | Derivative | Feb 26, 2026 | Grant/Award | 274,493 | $0.00 | $0.00 | 274,493 | Direct | โ | View Details |